enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Endo International - Wikipedia

    en.wikipedia.org/wiki/Endo_International

    Endo is one of the companies named in lawsuits by the states of Ohio, [42] Missouri and Mississippi [43] as responsible for the US opioid epidemic. Its 10-K statement indicates that a majority of the company's US revenue in 2016 was derived from the sale of prescription pain killers, predominantly opioids. [44]

  3. List of opioids - Wikipedia

    en.wikipedia.org/wiki/List_of_opioids

    This is a list of opioids, opioid antagonists and inverse agonists. Opium and poppy straw derivatives. Seedhead of opium poppy with white latex.

  4. List of Schedule I controlled substances (U.S.) - Wikipedia

    en.wikipedia.org/wiki/List_of_Schedule_I...

    This is the list of Schedule I controlled substances in the United States as defined by the Controlled Substances Act. [1] The following findings are required for substances to be placed in this schedule: [2] The drug or other substance has a high potential for abuse.

  5. McKinsey to pay $650 million after advising opioid maker on ...

    www.aol.com/mckinsey-pay-650-million-advising...

    McKinsey & Company agreed to pay $650 million to resolve criminal and civil investigations into its advice to opioids manufacturer Purdue ... This popular vitamin C serum is on sale for just $10 ...

  6. Consulting firm McKinsey to pay $650 million to resolve US ...

    www.aol.com/consulting-firm-mckinsey-pay-650...

    McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...

  7. McKinsey & Company agrees to pay $650M for helping ... - AOL

    www.aol.com/mckinsey-company-agrees-pay-650...

    McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly addictive ...

  8. List of off-label promotion pharmaceutical settlements

    en.wikipedia.org/wiki/List_of_off-label...

    The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...

  9. Tennessee regulations prevent good addiction treatment for ...

    www.aol.com/tennessee-regulations-prevent-good...

    The law (TN Code 53-11-311) that prevents nurse practitioners (NPs) or physician assistants (PAs) from prescribing more than 16 milligrams of buprenorphine-naloxone daily (despite standard dosing ...